XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
 [1]
Accumulated Deficit [Member]
Total Precipio, Inc. [Member]
Noncontrolling Interest in Joint Venture [Member]
Total
Balance at beginning of period at Dec. 31, 2021   $ 11 [1] $ 104,647 $ (80,094) $ 24,564 $ 40 $ 24,604
Balance at beginning of period (in shares) at Dec. 31, 2021 47 1,135,422 [1]          
Increase (Decrease) in Stockholders' Equity              
Net loss       (9,913) (9,913) 18 (9,895)
Issuance of common stock in connection with at the market offering, net of issuance costs     129   129   129
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares) [1]   4,251          
Proceeds upon issuance of common stock from exercise of warrants     11   11   11
Proceeds upon issuance of common stock from exercise of warrants (in shares) [1]   1,340          
Stock-based compensation     3,405   3,405   3,405
Balance at end of period at Sep. 30, 2022   $ 11 [1] 108,192 (90,007) 18,196 58 18,254
Balance at end of period (in shares) at Sep. 30, 2022 47 1,141,013 [1]          
Balance at beginning of period at Jun. 30, 2022   $ 11 [1] 107,330 (86,828) 20,513 52 20,565
Balance at beginning of period (in shares) at Jun. 30, 2022 47 1,135,435 [1]          
Increase (Decrease) in Stockholders' Equity              
Net loss       (3,179) (3,179) 6 (3,173)
Issuance of common stock in connection with purchase agreements, net of issuance costs     129   129   129
Issuance of common stock in connection with purchase agreements, net of issuance costs (in shares) [1]   4,251          
Proceeds upon issuance of common stock from exercise of warrants     11   11   11
Proceeds upon issuance of common stock from exercise of warrants (in shares) [1]   1,327          
Stock-based compensation     722   722   722
Balance at end of period at Sep. 30, 2022   $ 11 [1] 108,192 (90,007) 18,196 58 18,254
Balance at end of period (in shares) at Sep. 30, 2022 47 1,141,013 [1]          
Balance at beginning of period at Dec. 31, 2022   $ 11 [1] 108,588 (92,297) 16,302 65 16,367
Balance at beginning of period (in shares) at Dec. 31, 2022 47 1,141,013 [1]          
Increase (Decrease) in Stockholders' Equity              
Net loss       (6,778) (6,778)   (6,778)
Payment of fractional common shares in conjunction with the reverse stock split. [1]   (52)          
Issuance of common stock in connection restricted stock awards     16   16   16
Issuance of common stock in connection restricted stock awards (in shares) [1]   2,492          
Issuance of common stock in connection with purchase agreements, net of issuance costs   $ 2 [1] 1,758   1,760   1,760
Issuance of common stock in connection with purchase agreements, net of issuance costs (in shares) [1]   206,250          
Issuance of common stock in connection with at the market offering, net of issuance costs   $ 1 [1] 484   485   485
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares) [1]   30,852          
Stock-based compensation     1,152   1,152   1,152
Balance at end of period at Sep. 30, 2023   $ 14 [1] 111,998 (99,075) 12,937 65 13,002
Balance at end of period (in shares) at Sep. 30, 2023 47 1,380,555 [1]          
Balance at beginning of period at Jun. 30, 2023   $ 14 [1] 111,632 (97,620) 14,026 65 14,091
Balance at beginning of period (in shares) at Jun. 30, 2023 47 1,378,115 [1]          
Increase (Decrease) in Stockholders' Equity              
Net loss       (1,455) (1,455)   (1,455)
Payment of fractional common shares in conjunction with the reverse stock split. [1]   (52)          
Issuance of common stock in connection restricted stock awards     16   16   16
Issuance of common stock in connection restricted stock awards (in shares) [1]   2,492          
Stock-based compensation     350   350   350
Balance at end of period at Sep. 30, 2023   $ 14 [1] $ 111,998 $ (99,075) $ 12,937 $ 65 $ 13,002
Balance at end of period (in shares) at Sep. 30, 2023 47 1,380,555 [1]          
[1] The common stock and additional paid-in capital for all periods presented reflect the one-for-twenty reverse stock split, which was effected on September 21, 2023.